Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia - PubMed

Affiliations

• PMID: 16293608
• DOI: 10.1182/blood-2005-07-2853

Free article

Comparative Study

Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia

Stefan Schmidt et al. Blood. 2006.

Free article

Erratum in

• Blood. 2007 Apr 15;109(8):3234

Abstract

The ability of glucocorticoids (GCs) to kill lymphoid cells led to their inclusion in essentially all chemotherapy protocols for lymphoid malignancies, particularly childhood acute lymphoblastic leukemia (ALL). GCs mediate apoptosis via their cognate receptor and subsequent alterations in gene expression. Previous investigations, including expression profiling studies with subgenome microarrays in model systems, have led to a number of attractive, but conflicting, hypotheses that have never been tested in a clinical setting. Here, we present a comparative whole-genome expression profiling approach using lymphoblasts (purified at 3 time points) from 13 GC-sensitive children undergoing therapy for ALL. For comparisons, expression profiles were generated from an adult patient with ALL, peripheral blood lymphocytes from GC-exposed healthy donors, GC-sensitive and -resistant ALL cell lines, and mouse thymocytes treated with GCs in vivo and in vitro. This generated an essentially complete list of GC-regulated candidate genes in clinical settings and experimental systems, allowing immediate analysis of any gene for its potential significance to GC-induced apoptosis. Our analysis argued against most of the model-based hypotheses and instead identified a small number of novel candidate genes, including PFKFB2, a key regulator of glucose metabolism; ZBTB16, a putative transcription factor; and SNF1LK, a protein kinase implicated in cell-cycle regulation.

Similar articles

• Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells.

  Carlet M, Janjetovic K, Rainer J, Schmidt S, Panzer-Grümayer R, Mann G, Prelog M, Meister B, Ploner C, Kofler R. Carlet M, et al. BMC Cancer. 2010 Nov 23;10:638. doi: 10.1186/1471-2407-10-638. BMC Cancer. 2010. PMID: 21092265 Free PMC article.

• PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis.

  Wasim M, Carlet M, Mansha M, Greil R, Ploner C, Trockenbacher A, Rainer J, Kofler R. Wasim M, et al. J Steroid Biochem Mol Biol. 2010 Jun;120(4-5):218-27. doi: 10.1016/j.jsbmb.2010.04.019. Epub 2010 May 6. J Steroid Biochem Mol Biol. 2010. PMID: 20435142 Free PMC article.

• Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells.

  Tissing WJ, den Boer ML, Meijerink JP, Menezes RX, Swagemakers S, van der Spek PJ, Sallan SE, Armstrong SA, Pieters R. Tissing WJ, et al. Blood. 2007 May 1;109(9):3929-35. doi: 10.1182/blood-2006-11-056366. Epub 2007 Jan 11. Blood. 2007. PMID: 17218380 Clinical Trial.

• Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells.

  Thompson EB, Johnson BH. Thompson EB, et al. Recent Prog Horm Res. 2003;58:175-97. doi: 10.1210/rp.58.1.175. Recent Prog Horm Res. 2003. PMID: 12795419 Review.

• Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia.

  Kofler R, Schmidt S, Kofler A, Ausserlechner MJ. Kofler R, et al. J Endocrinol. 2003 Jul;178(1):19-27. doi: 10.1677/joe.0.1780019. J Endocrinol. 2003. PMID: 12844332 Review.

Cited by

• Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia.

  Yadav BD, Samuels AL, Wells JE, Sutton R, Venn NC, Bendak K, Anderson D, Marshall GM, Cole CH, Beesley AH, Kees UR, Lock RB. Yadav BD, et al. Oncotarget. 2016 Sep 13;7(37):58728-42. doi: 10.18632/oncotarget.11233. Oncotarget. 2016. PMID: 27623214 Free PMC article.

• The Human Blood Metabolome-Transcriptome Interface.

  Bartel J, Krumsiek J, Schramm K, Adamski J, Gieger C, Herder C, Carstensen M, Peters A, Rathmann W, Roden M, Strauch K, Suhre K, Kastenmüller G, Prokisch H, Theis FJ. Bartel J, et al. PLoS Genet. 2015 Jun 18;11(6):e1005274. doi: 10.1371/journal.pgen.1005274. eCollection 2015 Jun. PLoS Genet. 2015. PMID: 26086077 Free PMC article.

• Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia-The State-of-the-Art Knowledge and Future Prospects.

  Kośmider K, Karska K, Kozakiewicz A, Lejman M, Zawitkowska J. Kośmider K, et al. Int J Mol Sci. 2022 Mar 30;23(7):3795. doi: 10.3390/ijms23073795. Int J Mol Sci. 2022. PMID: 35409154 Free PMC article. Review.

• Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.

  Beesley AH, Rampellini JL, Palmer ML, Heng JY, Samuels AL, Firth MJ, Ford J, Kees UR. Beesley AH, et al. Mol Cancer. 2010 Oct 28;9:284. doi: 10.1186/1476-4598-9-284. Mol Cancer. 2010. PMID: 20979663 Free PMC article.

• HtrA serine proteases as potential therapeutic targets in cancer.

  Chien J, Campioni M, Shridhar V, Baldi A. Chien J, et al. Curr Cancer Drug Targets. 2009 Jun;9(4):451-68. doi: 10.2174/156800909788486704. Curr Cancer Drug Targets. 2009. PMID: 19519315 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • NIAID Data Ecosystem - Find datasets on Infectious and Immune-mediated Diseases

• Miscellaneous

  • NCI CPTAC Assay Portal